Follow
Ilina Micheva,  Илина Мичева, Ιλινα Μιτσεβα
Ilina Micheva, Илина Мичева, Ιλινα Μιτσεβα
Verified email at mu-varna.bg
Title
Cited by
Cited by
Year
Gene transfer into human hematopoietic progenitor cells with an episomal vector carrying an S/MAR element
EP Papapetrou, PG Ziros, ID Micheva, NC Zoumbos, A Athanassiadou
Gene therapy 13 (1), 40-51, 2006
1182006
Dendritic cells in patients with type I Gaucher disease are decreased in number but functionally normal
I Micheva, T Marinakis, C Repa, A Kouraklis-Symeonidis, V Vlacha, ...
Blood Cells, Molecules, and Diseases 36 (2), 298-307, 2006
382006
Defective tumor necrosis factor alpha-induced maturation of monocyte-derived dendritic cells in patients with myelodysplastic syndromes
I Micheva, E Thanopoulou, S Michalopoulou, M Karakantza, ...
Clinical Immunology 113 (3), 310-317, 2004
342004
Impaired generation of bone marrow CD34‐derived dendritic cells with low peripheral blood subsets in patients with myelodysplastic syndrome
I Micheva, E Thanopoulou, S Michalopoulou, T Kakagianni, ...
British journal of haematology 126 (6), 806-814, 2004
242004
Impaired clonogenic growth of myelodysplastic bone marrow progenitors in vitro is irrelevant to their apoptotic state
S Michalopoulou, I Micheva, A Kouraklis-Symeonidis, T Kakagianni, ...
Leukemia research 28 (8), 805-812, 2004
202004
Apoptosis in medfly hemocytes is regulated during pupariation through FAK, Src, ERK, PI‐3K p85a, and Akt survival signaling
I Mamali, MN Tatari, I Micheva, M Lampropoulou, VJ Marmaras
Journal of cellular biochemistry 101 (2), 331-347, 2007
172007
Infections in urinary tract of patients with haematological malignancies undergoing antineoplastic therapy
S Tancheva, I Micheva, I Marinova, B Bojchev, M Marinov, K Nenov, ...
Hematology 15, 95-97, 2006
92006
One Health strategies for addressing antimicrobial resistance: an exclusive emphasis on Bulgaria
D Vankova, I Kapincheva, I Micheva, P Boncheva, S Mihaylova, ...
European Journal of Public Health 33 (Supplement_2), ckad160. 1026, 2023
82023
Incidence, risk factors and outcome of bloodstream infections in patients after hematopoietic stem-cell transplantation: A single center study
D Niyazi, I Micheva, K Dokova, T Stoeva
Indian Journal of Hematology and Blood Transfusion 39 (4), 610-614, 2023
62023
Expression and inducibility of cytoprotective heat shock proteins in the bone marrow of patients with myelodysplastic syndrome: correlation with disease progression
S Michalopoulou, I Micheva, M Karakantza, A Kouraklis-Symeonidis, ...
haematologica 91 (12), 1714-1716, 2006
62006
Acute myelogenous leukemia–current recommendations and approaches in molecular-genetic assessment
D Yahya, M Hachmeriyan, I Micheva, T Chervenkov
Romanian Journal of Internal Medicine 60 (2), 103-114, 2022
42022
18F-FDG PET/CT in the diagnosis of an extranodal relapse of diffuse large B-cell lymphoma (DLBCL): a clinical case with a literature review
B Chaushev, I Micheva, M Mechmed, B Balev, Y Bocheva, D Ivanova, ...
Nuclear Medicine Review 19 (B), 11-13, 2016
42016
Overexpansion ofThl7 and Thl/17 cells in patients with myelodysplastic syndrome
EE Solomou, A Tsanaktsi, V Fertakis
ASH Anuual Meeting and Exposition, 50th ed, San Francisco, 2008
42008
Dynamics of bone disease biomarkers dickkopf-1 and sclerostin in patients with multiple myeloma
V Gerov, D Gerova, I Micheva, M Nikolova, G Mihaylova, B Galunska
Journal of Clinical Medicine 12 (13), 4440, 2023
32023
Species diversity and antimicrobial resistance of Staphylococcus spp. isolates associated with catheter-related bloodstream infections in patients after hematopoietic stem cell …
D Niyazi, I Micheva, D Savova, M Georgieva, E Ismail, T Stoeva
Scripta Scientifica Medica 54 (2), 13-17, 2022
32022
PB1912 EFFICACY AND SAFETY OF RITUXIMAB BIOSIMILAR TRUXIMA IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA AND NON-HODGKIN'S LYMPHOMAS
I Micheva, S Useir, L Gercheva
HemaSphere 3 (S1), 871, 2019
32019
P060 CD34+ marrow cells from MDS patients are characterized by higher levels of intracellular reactive oxygen species and inadequate antioxidant defences
G Voukelatou, E Thanopoulou, K Dallas, V Fertakis, A Dimopoulou, ...
Leukemia research, S93-S94, 2009
32009
Introducing innovative policy instrument to reduce antibiotics use. Relevant evidence from Bulgaria
D Vankova, N Veleva, S Mihaylova, P Boncheva, M Vladimirova, ...
European Journal of Public Health 34 (Supplement_3), ckae144. 1132, 2024
22024
In vitro activity of ceftazidime-avibactam against ESBL producing and carbapenem-resistant gram–negative bacteria recovered from blood and fecal samples of patients after …
D Niyazi, I Micheva, D Savova, T Stoeva
MDPI, 2022
22022
Efficacy of Inotuzumab Ozogamicin plus Ponatinib Followed by Allogeneic Stem Cell Transplantation in a Patient with Relapsed Philadelphia Chromosome‐Positive Acute …
I Micheva, V Gerov, S Dimitrova, M Efraim
Case Reports in Hematology 2021 (1), 1717506, 2021
22021
The system can't perform the operation now. Try again later.
Articles 1–20